Back to User profile » Professor Sanjay Garg
Papers published by Professor Sanjay Garg:
Harmonising IV Oxycodone with Paediatric Perioperative Medications: A Compatibility Study Through Y-Type Connectors
Youssef SH, Garg A, Song Y, Wylie NE, Garg S
Drug Design, Development and Therapy 2024, 18:899-908
Published Date: 22 March 2024
Development and Optimization of Imiquimod-Loaded Nanostructured Lipid Carriers Using a Hybrid Design of Experiments Approach
Kim S, Abdella S, Abid F, Afinjuomo F, Youssef SH, Holmes A, Song Y, Vaidya S, Garg S
International Journal of Nanomedicine 2023, 18:1007-1029
Published Date: 22 February 2023
Pharmaceutical Development of 5-Fluorouracil-Eluting Stents for the Potential Treatment of Gastrointestinal Cancers and Related Obstructions
Arafat M, Song Y, Brewer K, Fouladian P, Parikh A, Albrecht H, Blencowe A, Garg S
Drug Design, Development and Therapy 2021, 15:1495-1507
Published Date: 9 April 2021
Perindopril in Breast Milk and Determination of Breastfed Infant Exposure: A Prospective Observational Study
Leggett C, Lwin EMP, Ritchie U, Song Y, Gerber JP, Turner S, Hague WM, Stark M, Upton R, Garg S
Drug Design, Development and Therapy 2020, 14:961-967
Published Date: 2 March 2020
Transfer of rosuvastatin into breast milk: liquid chromatography–mass spectrometry methodology and clinical recommendations
Lwin EMP, Leggett C, Ritchie U, Gerber C, Song Y, Hague W, Turner S, Upton R, Garg S
Drug Design, Development and Therapy 2018, 12:3645-3651
Published Date: 29 October 2018
Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer’s disease model
Parikh A, Kathawala K, Li JT, Chen C, Shan Z, Cao X, Wang YJ, Garg S, Zhou XF
Drug Design, Development and Therapy 2018, 12:2111-2128
Published Date: 9 July 2018
Self-nanomicellizing solid dispersion of edaravone: part I – oral bioavailability improvement
Parikh A, Kathawala K, Tan CC, Garg S, Zhou XF
Drug Design, Development and Therapy 2018, 12:2051-2069
Published Date: 5 July 2018
Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
Zhang W, Song Y, Eldi P, Guo X, Hayball JD, Garg S, Albrecht H
International Journal of Nanomedicine 2018, 13:293-305
Published Date: 9 January 2018
Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
Zhang B, Song YM, Wang TQ, Yang SM, Zhang J, Liu YJ, Zhang N, Garg S
International Journal of Nanomedicine 2017, 12:2871-2886
Published Date: 7 April 2017
Development of intramammary delivery systems containing lasalocid for the treatment of bovine mastitis: impact of solubility improvement on safety, efficacy, and milk distribution in dairy cattle
Wang W, Song Y, Petrovski K, Eats P, Trott DJ, Wong HS, Page SW, Perry J, Garg S
Drug Design, Development and Therapy 2015, 9:631-642
Published Date: 22 January 2015
Development of a novel niosomal system for oral delivery of Ginkgo biloba extract
Jin Y, Wen JY, Garg S, Liu D, Zhou YL, Teng LR, Zhang WY
International Journal of Nanomedicine 2013, 8:421-430
Published Date: 24 January 2013